Concepedia

Author

Céline Adessi

Roche (Switzerland)ORCID

Also Known As

C Adessi, C. Adessi, Celine Adessi, Céline Adessi

86

Publications

2.1K

Citations

18

H-Index

35

Concepts

All Affiliations

Roche (Switzerland)Roche (United Kingdom)CEA GrenobleCommissariat à l'Énergie Atomique et aux Énergies AlternativesPfizer (United Kingdom)
CA

About

Céline Adessi is an author at Roche (Switzerland) specializing in medicine, natural sciences, and cellular biochemistry.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

6

6

320

2

Natural Sciences

4

4

239

3

Biochemistry

4

4

239

4

Engineering

1

1

51

5

Biomedical Engineering

1

1

51

Céline Adessi

×

18

Publications

1.4K

Citations

16

H-Index

YearCitations

Solid phase DNA amplification: characterisation of primer attachment and amplification mechanisms

Céline Adessi

Nucleic Acids Research

2000

298

Reduction of amyloid load and cerebral damage in transgenic mouse model of Alzheimer's disease by treatment with a β‐sheet breaker peptide

Bruno Permanne, Céline Adessi, Gabriela P. Saborı́o,

The FASEB Journal

2002

217

Pharmacological Profiles of Peptide Drug Candidates for the Treatment of Alzheimer's Disease

Céline Adessi, Marie-José Frossard, Christophe Boissard,

Journal of Biological Chemistry

2003

195

Two‐dimensional electrophoresis of membrane proteins: A current challenge for immobilized pH gradients

Céline Adessi, Christine Miège, Catherine Albrieux,

Electrophoresis

1997

135

Phase Ib study evaluating safety and clinical activity of the anti-HER3 antibody lumretuzumab combined with the anti-HER2 antibody pertuzumab and paclitaxel in HER3-positive, HER2-low metastatic breast cancer

Andreas Schneeweiß, Tjoung‐Won Park‐Simon, Joan Albanell,

Investigational New Drugs

2018

70

89Zr-Lumretuzumab PET Imaging before and during HER3 Antibody Lumretuzumab Treatment in Patients with Solid Tumors

Frederike Bensch, Laetitia E. Lamberts, Michaël M. Smeenk,

Clinical Cancer Research

2017

69

First-in-Human Phase I Study of Lumretuzumab, a Glycoengineered Humanized Anti-HER3 Monoclonal Antibody, in Patients with Metastatic or Advanced HER3-Positive Solid Tumors

Didier Meulendijks, Wolfgang Jacob, Maria Martinez‐García,

Clinical Cancer Research

2015

68

Characterization of Dictyostelium discoideum cathepsin D Molecular cloning, gene disruption, endo-lysosomal localization and sugar modifications

Agnès Journet, Agnès Chapel, Stéphanie Jehan,

Journal of Cell Science

1999

64

Identification of major proteins associated with <i>Dictyostelium discoideum</i> endocytic vesicles

Céline Adessi, Agnès Chapel, Mathilde Vinçon,

Journal of Cell Science

1995

59

Beta‐sheet breaker strategy for the treatment of Alzheimer's disease

Céline Adessi, Claudio Soto

Drug Development Research

2002

51

Page 1